Top Markets
Coin of the day
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc.

VIAP
Clasificación en acciones #41780
VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily... VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily focused on discovering and advancing therapeutic compounds for cardiovascular and metabolic disorders. The firm is building a portfolio of small-molecule drug candidates designed to tackle the root causes of these health issues, such as vascular inflammation, elevated cholesterol and triglyceride levels, and insulin resistance or diabetes. Notable candidates in their development pipeline include: VIA-3196: A liver-specific thyroid hormone receptor (THR) beta agonist, poised for Phase 1 clinical studies. This drug aims to mitigate dyslipidemia, addressing high LDL cholesterol, elevated triglycerides, and Lp(a) levels. A Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor: Currently in preclinical development for treating type 2 diabetes, with promising potential for weight management and other lipid disorders. VIA-2291: A 5-Lipoxygenase inhibitor that has successfully completed its third Phase 2 clinical trial. Its purpose is to target atherosclerotic plaque, a significant contributor to heart attacks, strokes, and various other vascular diseases. VIA Pharmaceuticals has also forged two research, development, and commercialization agreements with Hoffman-LaRoche Inc. and Hoffman-LaRoche Ltd. These collaborations pertain to their THR beta agonist program and several compounds from their preclinical DGAT1 metabolic disorders initiative. Established in 2004, the company's headquarters are located in San Francisco, California.
Precio por acción
$0.0005
Última sincronización: 2026-08-11
Capitalización bursátil
$10.28K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio VIA Pharmaceuticals, Inc. (VIAP)

Categoría

Historial del precio de la acción de VIA Pharmaceuticals, Inc. (VIAP)
Precio más alto de cierre: $0.00 el 2026-08-01

Precio más bajo de cierre: $5.07 el 2007-06-01
Historial del precio de la acción de VIA Pharmaceuticals, Inc. desde 2007 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 10.50%
2024 45,147.62%
2023 0.00%
2022 0.00%
2021 -99.97%
2020 10.50%
2019 6.53%
2018 -48.67%
2017 89.41%
2016 -30.00%
2015 -73.45%
2014 11.70%
2013 -20.93%
2012 118.55%
2011 -85.81%
2010 -81.24%
2009 64.56%
2008 -92.98%
2007 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$59.08 62.03%
US
$49.68 72.21%
SE
$184.45 43.36%
FR
$62.39 4.91%
IT
$113.04 55.27%
US